FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test
FRIENDSWOOD, Texas, July 23, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that...
Cancer
European Commission approves DARZALEX® (daratumumab) as the first licensed treatment for patients with high-risk smouldering multiple myeloma
Landmark approval is based on results from the Phase 3 AQUILA study, showing fixed-duration treatment with daratumumab significantly reduced the...
Medicus Pharma Ltd. Announces Voting Results Following the Annual and Special Meeting of Shareholders
The Company added Congresswoman Cathy McMorris Rodgers & Ajay Raju, Esq. to the Board of Directors.Philadelphia, Pennsylvania--(Newsfile Corp. - July...
Sona Announces Canadian Melanoma Clinical ‘Pilot’ Study Ethics Approval
Halifax, Nova Scotia--(Newsfile Corp. - July 23, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an...
Oncolytics Biotech® Regains Compliance with Nasdaq Trading Rules
SAN DIEGO and CALGARY, AB, July 22, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a...
St. Baldrick’s Foundation Funds $10 Million in Grants to Accelerate Lifesaving Childhood Cancer Research
Los Angeles, California--(Newsfile Corp. - July 22, 2025) - The St. Baldrick's Foundation, the largest charity funder of childhood cancer...
KROMATID Works With Consortium to Empower Cancer Genomics with Industry-Leading Sequencing Standards
BOULDER, Colo., July 22, 2025 /PRNewswire/ -- KROMATID proudly announces its pivotal role within a groundbreaking public–private–academic consortium - including...
From Diagnosis to Surgery: How AI Tech Is Quietly Reshaping Healthcare Profits
USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 22, 2025 /PRNewswire/ -- USA News Group...
Caris Life Sciences Validates and Extends Findings on Tumor-Infiltrating Clonal Hematopoiesis
Validation was shared via a Letter to the Editor in the New England Journal of Medicine IRVING, Texas, July 22,...
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025
BOSTON and ROLLE, Switzerland, July 22, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in...
Kaida BioPharma Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
– Video webcast now available on-demand FORT LAUDERDALE, FL, July 22, 2025 (GLOBE NEWSWIRE) -- Kaida BioPharma (“Kaida” or the...
Akari Therapeutics Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
Video webcast now available on-demandBOSTON and LONDON, July 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology...
Senti Biosciences Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
– Video webcast now available on-demandSOUTH SAN FRANCISCO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI)...
Autonomix Medical, Inc. Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
– Video webcast now available on-demand THE WOODLANDS, TX, July 22, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX)...
Moleculin Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
– Video webcast now available on-demand HOUSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or...
SS Innovations Announces Completion of World’s First Intercontinental Robotic Cardiac Telesurgery
Performed by Dr. Sudhir Srivastava utilizing the Company’s SSi Mantra 3 surgical robotic system Remotely conducted from IRCAD in Strasbourg,...
Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd
WEXFORD, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen...
Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025
BRISBANE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical...
InStride Health Strengthens Executive Team with Appointment of Chief Commercial Officer and Chief Financial Officer
Veteran consumer and healthcare leaders will support InStride’s mission to scale evidence-based pediatric mental health careBOSTON, July 22, 2025 (GLOBE...
Autonomix Medical, Inc. Exercise of Warrants for $2.5 Million Gross Proceeds
THE WOODLANDS, TX, July 22, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device...